Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Efficacy and safety of darolutamide in Black/African-American patients from the phase III ARAMIS study.
Journal: Future oncology (London, England)
Published: February 08, 2023
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial.
Journal: The Journal of urology
Published: August 26, 2021
Showing 1-2 of 2
Last Updated: 09/26/2026